Abstract:Background CD38 belongs to the ribosyl cyclase family and is expressed on various hematological cells and involved in immunosuppression and tumor promotion. Although targeting CD38 antibodies has been approved for treatment of multiple myeloma, the function of CD38 in solid tumor, oral squamous cell carcinoma (OSCC) etc., has not been investigated. Methods This retrospective study included 92 OSCC samples and analyzed the spatial distribution of CD38 by immunohistochemistry (IHC). The values of diagnosis and prognosis of CD38 were evaluated. Additionally, 53 OSCC preoperative peripheral blood samples were used to be analyzed by flow cytometry. Tumor Immune Estimation Resource (TIMER) and cBioPortal databases were used to study CD38 level in various tumors and its correlation with tumor immune microenvironment in head and neck squamous cell carcinoma (HNSCC). Results CD38 ubiquitously presented in tumor cells (TCs), fibroblast-like cells (FLCs), and tumor-infiltrating lymphocytes (TILs). Patients with highly expressed CD38 in TCs (CD38(TCs)) had higher TNM stage and risk of lymph node metastasis. Upregulation of CD38 in FLCs (CD38(FLCs)) was significantly associated with poor WPOI. Escalated CD38 in TILs (CD38(TILs)) led to higher Ki-67 level of tumor cells. Moreover, patients with enhanced CD38(TCs) were susceptible to postoperative metastasis occurrence, and those with highly expressed CD38(TILs) independently predicted shorter overall and disease-free survival. Strikingly, patients with highly expressed CD38(TILs), but not CD38(TCs) and CD38(FLCs), had significantly lower CD3(+)CD4(+) T cells and higher ratio of CD3(-)CD16(+)CD56(+)NK cells. The imbalance of immune system is attributed to dysregulated immune checkpoint molecules (VISTA, PD-1, LAG-3, CTLA-4, TIGIT, GITR) as well as particular immune cell subsets, which were positively correlated with CD38 expression in HNSCC. Conclusion CD38 is a poor prognostic biomarker for OSCC patients and plays a vital role in governing immune microenvironment and circulating lymphocyte homeostasis. Co-expression between CD38 and immune checkpoint molecules provides new insight into immune checkpoint therapy.

Expression and Clinical Significance of Rab38 in Oral Squamous Cell Carcinoma

CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint.

Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction.

Increased Expression of FOXD1 is Associated with Cervical Node Metastasis and Unfavorable Prognosis in Oral Squamous Cell Carcinoma

Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma

Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC)

DDX59-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in OSCC.

Expression Value of Rab10 in Breast Cancer

Expression and significance of survivin in oral squamous cell carcinoma

An Association Study on Genetic Polymorphisms of Rab37 Gene with the Risk of Esophageal Squamous Cell Carcinoma in a Chinese Han Population.

Long non-coding RNA SAMMSON as a novel potential diagnostic and prognostic biomarker for oral squamous cell carcinoma

Express of Mir-17-5p in Oral Squamous Cell Carcinoma and Its Clinical Significance

Expression of OLR1 gene on tumor-associated macrophages of head and neck squamous cell carcinoma, and its correlation with clinical outcome

Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome

CT-based radiomics predicts CD38 expression and indirectly reflects clinical prognosis in epithelial ovarian cancer

Significance of Expressions of Osteopontin and Ras in Laryngeal Squamous Cell Carcinoma and Their Correlation

Clinical Significance of the Decreased Expression of Hsa_circ_001242 in Oral Squamous Cell Carcinoma

A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment

RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance

Prognostic value of T regulatory cells and immune checkpoints expression in tumor-draining lymph nodes for oral squamous cell carcinoma